Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment

Pr Michel GILLIET, Riedel T, Demaria O, Zava O, Joncic A, Dyson PJ. Drug Repurposing


Diversification of human plasmacytoid predendritic cells in response to a single stimulus

Pr Michel GILLIET, Alculumbre SG, Saint-André V, Di Domizio J, Vargas P, Sirven P, Bost P, Maurin M, Maiuri P, Wery M, Roman MS, Savey L, Touzot M, Terrier B, Saadoun D, Conrad C, Morillon A, Soumelis V.

Nat Immunol


TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis

Pr Michel GILLIET, Conrad C, Di Domizio J, Mylonas A, Belkhodja C, Demaria O, Navarini AA, Lapointe AK, French LE, Vernez M

Nat Commun


Psoriasis: from Pathogenesis to Targeted Therapies

Pr Michel GILLIET, Conrad C

Clin Rev Allergy Immunol